Key Benefits

• Very effective in hypercholesterolemia
  
  
• Significantly reduces mortality, CHD, non-fatal MI and the need for revascularisation procedures
  
  
• Convenient single daily dose
  
  
• A marked response to Corstat is seen within two weeks and the maximum therapeutic response occurs within four to six weeks. The response is maintained during continuation of therapy
  
  
• Remains stable for 18 hours after reconstitution below 25°C and for 7 days if refrigerated

Indications

In patients with coronary heart disease with a plasma cholesterol level
of 5.5 mmol/l or greater, Corstat is indicated to:

• Reduce the risk of mortality
  
  
• Reduce the risk of coronary death and non-fatal myocardial infarction
  
  
• Reduce the risk for undergoing myocardial revascularisation procedures
  
  
• Slow the progression of coronary atherosclerosis, including reducing the development of new lesions and new total occlusions

* The patient should be placed on a standard cholesterol-lowering
diet before receiving Corstat and should continue on this diet during treatment with Corstat.